<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-162696</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Autochthonous acute hepatitis E: an increasingly frequent diagnosis. Clinical-epidemiological analysis of our experience</dc:title>
<dc:description xml:lang="en">Background: In Europe, acute hepatitis caused by the hepatitis E virus (HEV) traditionally was an infection found in people who had travelled to endemic zones, mainly Asia and Africa. However, a growing number of sporadic autochthonous cases are now being diagnosed in the Western world. Objective: To analyze the cases of acute HEV hepatitis diagnosed in our setting, with the identification of the clinical-epidemiological characteristics. Material and methods: We included the cases of acute HEV hepatitis diagnosed (positive anti-HEV IgM and/or HEV RNA present in serum) between January 2008 and December 2014. Different clinical, epidemiological and evolutive parameters were analyzed. Results: A total of 23 patients were identified, all originating from Spain. Fourteen cases (60.87%) presented jaundice and marked cytolysis at the time of diagnosis (aspartate aminotransferase [AST] 1,106.91 U/l and alanine aminotransferase [ALT] 1,407.04 U/l). Twenty-two cases were regarded as autochthonous, and one patient had travelled to China three months before. The mean time to resolution was 11.2 weeks. Some autoimmune markers were positive in 43.5% of the patients. Two subjects were diagnosed with previous chronic liver disease and were classified as 'acute-on-chronic liver failure' (ACLF), one died and the other underwent liver transplantation. Conclusion: Acute HEV hepatitis in our setting is an autochthonous condition that is probably underdiagnosed, manifesting with jaundice and cytolysis. Autoimmune marker positivity is an epiphenomenon, which in some cases complicates the diagnosis (AU)</dc:description>
<dc:creator>Linares Torres, Pedro</dc:creator>
<dc:creator>Álvarez Cuenllas, Begoña</dc:creator>
<dc:creator>Valverde Romero, Emilio D</dc:creator>
<dc:creator>Monteserín Ron, Luzdivina</dc:creator>
<dc:creator>Miguel Peña, Aleida</dc:creator>
<dc:creator>Jorquera Plaza, Francisco</dc:creator>
<dc:creator>Jiménez Palacios, Marcos</dc:creator>
<dc:creator>Fernández-Natal, Isabel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Antecedentes: la hepatitis aguda por virus de la hepatitis E (VHE) en Europa era tradicionalmente una infección adquirida por personas que viajaban a zonas endémicas, fundamentalmente Asia y África. Actualmente, cada vez es mayor el número de casos autóctonos esporádicos diagnosticados en Occidente. Objetivo: analizar los casos diagnosticados de hepatitis aguda por virus hepatitis E (VHE) en nuestro medio, identificando las características clínicas-epidemiológicas. Material y método: se recogieron los casos diagnosticados de hepatitis aguda por VHE (IgM anti-VHE positiva y/o ARN-VHE presente en suero) desde enero de 2008 a diciembre 2014. Se analizaron diversas variables clínicas y epidemiológicas y la evolución posterior. Resultados: se encontraron 23 casos, todos ellos naturales de España. Catorce sujetos (60,87%) presentaban ictericia en el momento del diagnóstico y marcada citolisis (aspartato aminotransferasa [AST] 1.106,91 U/l y alanina aminotransferasa [ALT] 1.407,04 U/l). Veintidós casos fueron considerados autóctonos y uno había realizado un viaje a China tres meses antes. El tiempo medio de resolución fue de 11,2 semanas. En total, diez pacientes (43,5%) mostraban algún marcador de autoinmunidad positivo. Dos sujetos estaban diagnosticados de enfermedad hepática crónica previa y fueron catalogados como 'acute-on-chronic liver failure' (ACLF); uno de ellos finalizó en exitus y el otro, en trasplante hepático. Conclusión: la hepatitis aguda por VHE en nuestro medio es una entidad autóctona, probablemente infradiagnosticada, que se manifiesta con ictericia y citolisis. La presencia de marcadores de autoinmunidad positivos supone un epifenómeno que en ocasiones dificulta su diagnóstico (AU)</dc:description>
<dc:source>Rev Esp Enferm Dig;109(5): 344-349, mayo 2017. tab</dc:source>
<dc:identifier>ibc-162696</dc:identifier>
<dc:title xml:lang="es">Hepatitis aguda virus E autóctona. Un diagnóstico en aumento. Análisis clínico-epidemiológico de nuestra experiencia</dc:title>
<dc:subject>^d22207^s22002</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d30054^s22016</dc:subject>
<dc:subject>^d22443^s22045</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d22206^s22002</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d33349^s22016</dc:subject>
<dc:subject>^d30668^s22012</dc:subject>
<dc:subject>^d30054^s22080</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d7734^s22012</dc:subject>
<dc:subject>^d24529^s22031</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d6658^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201705</dc:date>
</metadata>
</record>
</ibecs-document>
